Antibody-mediated inhibition of MICA and MICB shedding promotes NK cell-driven tumor immunity

作者：de Andrade, Lucas Ferrari; Tay, Rong En; Pan, Deng; Luoma, Adrienne M.; Ito, Yoshinaga; Badrinath, Soumya; Tsoucas, Daphne; Franz, Bettina; May, Kenneth F., Jr.; Harvey, Christopher J.; Kobold, Sebastian; Pyrdol, Jason W.; Yoon, Charles; Yuan, Guo-Cheng; Hodi, F. Stephen; Dranoff, Glenn; Wucherpfennig, Kai W.^*

来源：Science, 2018, 359(6383): 1537-+.

DOI：10.1126/science.aao0505

• I-RELATED CHAIN
• NKG2D RECEPTOR
• T-CELLS
• CUTTING EDGE
• LIGANDS
• EXPRESSION
• ACTIVATION
• CANCER
• CYTOTOXICITY
• MOLECULES

MICA and MICB are expressed by many human cancers as a result of cellular stress, and can tag cells for elimination by cytotoxic lymphocytes through natural killer group 2D (NKG2D) receptor activation. However, tumors evade this immune recognition pathway through proteolytic shedding of MICA and MICB proteins. We rationally designed antibodies targeting the MICA alpha 3 domain, the site of proteolytic shedding, and found that these antibodies prevented loss of cell surface MICA and MICB by human cancer cells. These antibodies inhibited tumor growth in multiple fully immunocompetent mouse models and reduced human melanoma metastases in a humanized mouse model. Antitumor immunity was mediated mainly by natural killer (NK) cells through activation of NKG2D and CD16 Fc receptors. This approach prevents the loss of important immunostimulatory ligands by human cancers and reactivates antitumor immunity.

• 出版日期2018-3-30